MALIGNANT PLEURAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

Size: px
Start display at page:

Download "MALIGNANT PLEURAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES"

Transcription

1 MALIGNANT PLEURAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

2 Coordinator: Jan van Meerbeeck (Thoracic Oncology, MOCA, UZ Antwerpen) Authors: Jan van Meerbeeck (Thoracic Oncology, MOCA, UZ Antwerpen), Kurt Tournoy (Respiratory Medicine/Thoracic Oncology, OLV-Aalst), Yolande Lievens (Radiation Oncology, UZ Gent), Myriam Remmelink (Surgical Pathology, Hôpital Erasme ULB), Kristiaan Nackaerts (Pneumology/Respiratory Oncology, UZ Leuven), Philippe Nafteux (Thoracic Surgery, UZ Leuven), Thierry Berghmans (Medical Oncology, Institut Jules Bordet), Paul De Vuyst, (Pneumology, Hôpital Erasme ULB), Paul van Schil (Thoracic Surgery, UZ Antwerpen), Thierry Pieters (Pneumology, Cliniques universitaires Saint-Luc) Reviewers: Sylvie Lambin (Thoracic Oncology Nurse, Cliniques universitaires Saint-Luc), Marianne Fontaine (Physiotherapist, UZ Leuven), Esther Vandebosch (Psychologist, UZ Leuven), Patricia Eraets (Head Nurse, UZ Leuven), Nathalie Leclerq (Thoracic Oncology Nurse, Institut Jules Bordet), Yves Libert (Psychologist, Institut Jules Bordet), Sarah Houtman (Registered Thoracic Oncology Nurse, OLV Aalst), Ellen Troch (Clinical Psychologist, OLV-Aalst), Sisca Kohl (Oncology Nurse, UZ Antwerpen) Disclaimer : The coordinators of the working groups and all the authors listed by chapter have worked autonomously under the supervision of the KCE team. The KCE experts are not co-authors of these proposals and did not necessarily validate their content. Hospitals with which coordinators and authors of these proposals are affiliated are not de facto considered Reference Centres. Similarly, Belgian hospitals that are not represented in these proposals are not de facto considered Peripheral Centres. These proposals were not submitted to the external validators. This addendum only exists in English. No French or Dutch translation was done. Finally, the report to which this addendum refers has been approved by common assent by the Executive Board. Copyright : KCE reports are published under a by/nc/nd Creative Commons Licence This section is part of a whole document (KCE Report 219 Addendum) available on the website of the Belgian Health Care Knowledge Centre

3

4 KCE Report 219 Addendum Rare/complex cancers concrete proposals 1 PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES A. Type of cancer Mesothelioma of the pleura and the pericard B. Short description of the cancer The crude incident rates of malignant pleural and pericardial mesothelioma (MPM) in Belgium are 2.49 per for all cases, 4.15 per males and 0.90 per females. The mesothelioma incidence has substantially increased over the last 20 years to 273 incident cases in 2011 b, and will peak around 2020, with an ensuing smooth descending slope, reflecting the persistence of the main carcinogen asbestos in the environment. Presenting symptoms of mesothelioma are aspecific: chest pain due to chest wall involvement and/or dyspnoea due to pleural or pericardial effusion, the latter with tamponade of the heart. Although a diagnosis can be suspected on pleural or pericardial fluid cytology, a formal diagnosis and subtyping requires a tissue biopsy, typically obtained via thoracoscopy or transthoracic fine needle biopsy. The disease is considered almost universally fatal. Overall survival is dismal with < 5% of patients alive 5 years after diagnosis and even fewer disease free at that moment. Survival has however, been improving partly by an earlier diagnosis and for patients diagnosed in the one year relative survival estimates were 44.5% in males and 49.5% in females. Whereas complete resection is controversial, a minority of patients (<10%) might benefit from cytoreductive or debulking surgery by either extrapleural pneumonectomy or pleurectomy/decortication as part of a multimodality treatment protocol. Both procedures are complex and require expertise and a dedicated care pathway. MPM is a highly symptomatic cancer and access to specialist palliative interventions will form an important part of any high quality service. b

5 2 Rare/complex cancers concrete proposals KCE Report 219 Addendum C. Model of care pathway suggested for adult patients with MPM Model of care pathway: A stepped care design Step A: Regional MPM reference centres will be installed, where treatment with radical intent and clinical trials are centralized. Treatment with radical intent includes any attempt at radical resection and/or definitive radiotherapy of the primary tumour, whether or not experimental. At (suspected) diagnosis, all fit patients should be discussed with the specialist mesothelioma multidisciplinary team from the nearest malignant pleural mesothelioma centre in order to select those patients for referral for these treatments. Step B: Radical surgery of any kind will be concentrated in appropriate thoracic surgical reference centres. Although such a surgical reference centre has to be located in a MPM reference centre s institution, the inverse does not apply; a MPM reference centre should not necessarily qualify as surgical reference centre. In the latter case, MPM and surgical reference centres function however, as close partners; for peri-operative hemi-thorax radiotherapy, e.g. in the context of a treatment with radical intent, the radiation and surgical oncologists partner up in the same MPM centre (see further). Step C: Palliative therapy, including standard palliative chemotherapy or radiotherapy for symptom control, can be done in the peripheral centre, provided that the treatment is coordinated by a multidisciplinary team, including a pulmonologist with oncological competence and/or a medical oncologist, a clinical nurse specialist, a psychologist with a specific training in psycho-oncology and/or in palliative care, a pain specialist, all in close collaboration with primary care and palliative care services. D. Phase(s) of the clinical pathway for which Reference Centres are required Phase of the Clinical Pathway MPM Reference Centre Peripheral Centre 0 Application for compensation to Fund of Occupational Diseases or Asbestos Fund according to Belgian legislation 1 MOC (at diagnosis) X: 2 nd opinion MOC X 2 Diagnostic confirmation National Mesothelioma Panel 3a Diagnostic procedures i.c. thoracoscopy X 3b Invasive staging procedures X 4a Treatment with palliative intent, including standard chemotherapy, radiotherapy, pleurodesis 4b Treatment with radical intent, inclusive any attempt of multimodality treatment including extended surgery X (in collaboration with surgical reference centre) 4c Clinical intervention study, for the duration of the trial X 5 Follow-up (x for 4b/4c) X for 4a 6 At relapse X: 2 nd opinion MOC X X

6 KCE Report 219 Addendum Rare/complex cancers concrete proposals 3 Multidisciplinary Oncological Consult (MOC): Peripheral Centre and Reference Centre Eligibility for surgery and for clinical trials - with either systemic treatment and/or combined modality- requires a specific knowledge of staging, inclusion and exclusion criteria. This is done as a second opinion-moc, either by the physical presence of the referring physician at the reference centre s MOC, by teleconsulting (tele-moc) or after viewing the patient at a specialised consultation in the reference centre. Diagnostic confirmation: Reference Panel European guidelines c : An independent expert panel should be asked to confirm the diagnosis particularly in clinical trials, or in any case where there is doubt about the diagnosis. Belgian regulation: National pathology panel review required for compensation by Asbestos Fund or Occupational Diseases Fund Comprehensive anatomo-pathological diagnosis The diagnostic procedures leading to a diagnosis of MPM should be available and possible in every general hospital. It is noted that preference should be given to a histological diagnosis. Invasive staging in case of treatment with radical intent (e.g. mediastinoscopy or laparoscopy) should be done in the Reference Centre. Endoscopic Ultrasound (EBUS/EUS) can be performed in a Peripheral Centre, provided it is performed by an experienced pulmonologist and cytology is reviewed. Therapeutic modalities: Reference Centre European guidelines d advocate to perform: extended surgery only in selected patients by experienced thoracic surgeons in the context of a multidisciplinary team and preferably as part of a clinical trial of multimodality treatment; postoperative Intensity Modulated thoracic Radiotherapy (IMRT) in specialised centres only; clinical trials in mesothelioma by multidisciplinary teams with a profound knowledge of staging and response evaluation; It was felt by the experts that extended resections in mesothelioma are not the remit of surgical departments without extensive thoracic surgical expertise. Follow-up: Reference Centre Only for those patients qualifying for treatment with radical intent (late toxicity) or for the duration of clinical trials. At relapse, fit patients should be presented at the MOC of the MPM Reference Centre in order to select and refer for participation in clinical trials. Eligibility for clinical trials requires a specific knowledge of inclusion and exclusion criteria. This is done as a second opinion-moc, either by the physical presence of the c d Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010; 35: Stahel RA, Weder W, Lievens Y, Felip E. On behalf of the ESMO Guidelines Working Group. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2010; 1 (Supplement 5): v126 a8

7 4 Rare/complex cancers concrete proposals KCE Report 219 Addendum referring physician at the reference centre s MOC, by tele-consulting (tele-moc) or after viewing the patient at a specialised consultation in the reference centre. E. General and specific minimal criteria for Reference Centres Human Resources and dedicated team Specialized staff: members of the specialist mesothelioma multidisciplinary team include the same range of professionals as the lung cancer multidisciplinary team. Each of the following specialities should be represented by at least 1 member: Pulmonologist with oncological competence and/or a medical oncologist with a special expertise in mesothelioma, taking managerial responsibility for the service as a whole; Thoracic surgeon with experience in the management of pleural disease including mesothelioma, working within the mesothelioma Reference Centre or in a partnered up thoracic surgical unit (see further); Radiation Oncologist with a special interest in thoracic oncology and experience in mesothelioma, working within the mesothelioma Reference Centre or in a partnered up radiotherapy department; Pathologist with experience in mesothelioma diagnosis; Nuclear medicine physician with expertise in thoracic oncology; Radiologist with thoracic expertise; A clinical nurse specialist, linked to the National Cancer Plan programme, with specialised knowledge of lung cancer and mesothelioma; Pain specialist with close links with the palliative care team. Multidisciplinary management All new fit patients are routinely presented at a specialized thoracic oncology MOC; Results of MOC are documented according to the standard requirements of the oncology care programme and Cancer Registry; Patients have access to a psychologist with a specific training in the psycho-oncology field, and provided through the oncology care program. If necessary a (liaison) psychiatrist can be consulted; Patients have access to dieticians, physiotherapists, social workers, provided through the oncology care programme; Adequate and sufficient support to provide the administrative coordination of the multidisciplinary team and the registration of outcome data and provided through the oncology care programme. Appropriate funding for keeping database and personnel to collect and send quality indicators and required treatment information to the Belgian Cancer Registry

8 KCE Report 219 Addendum Rare/complex cancers concrete proposals 5 Required facilities and equipment Adequate meetings of the National Mesothelioma Panel require an appropriate facility for tele-pathology for participants; Surgery: a thoracic surgery reference department is defined as proposed by the Belgian criteria for coordinating training centres in thoracic surgery e, either in house or partnered up to the MPM reference centre. A formal collaboration between thoracic surgeon and radiation oncologist is required with regard to postoperative radiotherapy planning; Radiotherapy: o planning systems that allow image fusion of different data sets as well as advanced dose computation algorithms (type B algorithms); o linear accelerators at least capable of Intensity Modulated Radio Therapy (IMRT) and Image Guided Radiotherapy (IGRT) (volumetric imaging, conebeam CT scan);f o motion management techniques are highly advisable. Chemotherapy is carried out by appropriate specialists and is compliant with local and national quality assurance regulations for chemotherapy administration and acute oncology; Imaging: all appropriate imaging inclusive dedicated PET-CT facility and image-guided biopsy modalities are available to patients in a timely manner; Laboratory for pathology has access to a range of appropriate immune-histochemical stainings; Specialist palliative care including treatment of refractory pain and dyspnoea; Dedicated MOC-room with simultaneous projection of imaging and patient data and optional tele-moc facilities; Access to tumour bank; Access to an oncological rehabilitation programme; Facilities for clinical trial conduct and support, including research nurse and data manager involved in oncology trials according to existing standards (International Conference on Harmonisation Good Clinical Practice (IHC-GCP). e f See addendum A IMRT is a high precision form of radiotherapy. It conforms the shape and dose of the radiation precisely to the volume of tumour tissue that needs to be treated; Image Guided Radiotherapy (IGRT) is any imaging at pre-treatment and delivery, the result of which is acted upon, that improves or verifies the accuracy of radiotherapy. IGRT encompasses the whole range from simple visual field alignment checks, through to the more complex volumetric imaging that allows direct visualization of the target volume and surrounding anatomy.

9 6 Rare/complex cancers concrete proposals KCE Report 219 Addendum Patient centred care Presence of comprehensive institutional Standard Operating Procedures detailing diagnostic, therapeutic management, continuity of care and follow-up of (suspected) mesothelioma patients; Core services cover continuity of care 24/7 by specialised staff in agreement with the reference centre s emergency department and house duty call rules. This applies for services provided by the departments of pulmonology, thoracic surgery, radiology, oncology and pain specialist; Support services for the patient are available through the Oncology care programme; National and international networking with other national and international Reference Centres for second opinion or specific indications which require further centralisation of expertise, e.g. cordotomy, pleural IMRT, experimental targeted treatment, referral to phase 1 clinical trials; Tele-MOC facilities with other hospitals and specialists in order to discuss eligibility for referral. Minimal volume of patients For MPM reference centres: after a run-in period of 5 years, an average caseload of at least 20 patients with mesothelioma per year, referred for either diagnosis, treatment or second opinion. Less than half of these should consist of second opinions, referred without further treatment in the reference centre. For surgical reference centres: as radical surgery is not a standard therapeutic approach for MPM, it is impossible to propose a minimal number of patients defining a reference surgery centre for radical mesothelioma surgery. Up to 10% of MPM patients are expected to receive radical surgery treatment, which corresponds to ± 30 patients /year in Belgium g. We propose that a surgical reference centre for radical/ extended mesothelioma surgery is defined as a coordinating training centre for thoracic surgery (as defined by the Belgicum Collegium Chirurgicum (addendum A)) and is handling - after a run-in period of 5 years - at least 5 patients per year by any kind of radical surgery. In case a surgeon trained in such a reference surgery centre aims to develop a programme for radical MPM surgery in another MPM reference centre, the same criteria have to be fulfilled to consider the reference centre as a new reference surgical centre. g Damhuis R, Khakwani A, de Schutter H, van Meerbeeck J, Rich A, Burgers J. International comparison of treatment and survival for pleural mesothelioma, combined analysis of patients from Belgium, the Netherlands and England. In press

10 KCE Report 219 Addendum Rare/complex cancers concrete proposals 7 Quality Assurance Diagnosis of the local pathologist should be confirmed within reasonable delay (< 2 weeks) by the specialist mesothelioma panel of pathologists. This frequency of meetings will require the financing of the installation of tele-pathology (see above). Annual activity report on number of new patients, diagnostic, treatment and outcome data. Capacity to propose quality indicators (structure, process, outcomes) o Structure indicator: composition of the multidisciplinary team and technical determinants of the centre o Process indicators Threshold 1. fraction of referred patients seen within 2 weeks of referral 95% 2. fraction of referred patients discussed at MOC of Reference Centre 100% 3. fraction of patients starting tumour directed treatment within 1 month after the MOC where the therapeutic decision was proposed 85% Outcome indicators day mortality of radical surgery (average on a 3 year base) <7% 90-day mortality of radical surgery (average on a 3 year base) <15% 5. 1-year and 5-year survival rate (to be provided by the Belgian Cancer Registry) Research and other scientific activities Participation to clinical trials in which patients with mesothelioma can be recruited, including local, national and international, observational, translational and interventional studies of any phase Medical team members versed in clinical management of patients have proficiency in mesothelioma care and in clinical trial conduct (GCP accreditation) Link with a tumour bank Quality indicators o fraction of referred patients are enrolled in a study over a period of 3 years 10% o fraction of operated patients having their tissue banked and linked with clinical data 80%

11 8 Rare/complex cancers concrete proposals KCE Report 219 Addendum Educational activities: Teaching and dissemination Involvement in training and continuous education programmes (annual or multi-annual training / educational programme for physicians, nurses, supportive disciplines) is encouraged. Organisation / communication in scientific congresses Organisational strategy to prevent burn-out or emotional fatigue and care for moral distress in caregivers (e.g. through meetings, intervision, training, coaching,...) Additional comments 1. As expertise is linked to experts, Reference Centres should be audited every 5 years for their performance based on the proposed quality indicators. 2. As knowledge about mesothelioma is rapidly evolving, the criteria for Reference Centres should be re-evaluated at least every 5 years, preferably with the aid of the KCE. 3. The instalment of Reference Centres for mesothelioma is conditional of the official recognition procedure of the titles of pulmonologist with oncological competence h and of general surgeon with thoracic surgical competence. 4. Care should be taken that the financing of the Reference Centres is appropriate and takes into account the multitude of extra tasks required. Addendum A: Minimal criteria to fulfill to be recognized as Coordinating Training Centre for Thoracic Surgery, as proposed by the Belgicum Collegium Chirurgicum 1. A centre dealing with all fields of General Thoracic Surgery, including Thoracic Oncology. 2. At least 75 major thoracic surgery operations per year should be performed in the centre. 3. At least two staff surgeons should be appointed full time in the centre, both bearing the title of Specific Competence in Thoracic Surgery and dedicating at least 50% of their activities to General Thoracic Surgery. One staff surgeon should have the degree of surgery for at least 8 years, the second for at least five years. 4. The centre should be held responsible for keeping records and patients files according to the at the moment accepted quality norms. 5. The centre should be responsible for the organization of training programs in Thoracic Surgery. 6. At least every 3 months, staff meeting for medical and paramedical staff should be organized. 7. Internal quality controls should be organized. h Federale Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu. Ministerieel besluit tot vaststelling van de bijzondere criteria voor de erkenning van geneesheren-specialisten, houders van de bijzondere beroepstitel in de medische oncologie en van de bijzondere beroepsbekwaamheid in de oncologie evenals van stagemeesters en stagediensten voor deze disciplines en deze bijzondere beroepsbekwaamheid. Belgisch Staatsblad N [C 2007/22836]/ Service Public fédéral Santé Publique, Sécurité de la Chaîne alimentaire et Environnement. Arrêté ministériel fixant les critères spéciaux d agréation des médecins spécialistes porteurs du titre professionnel particulier en oncologie médicale et de la qualification professionnelle particulière en oncologie ainsi que des maîtres de stage et des services de stage pour cette spécialité et cette qualification professionnelle particulière. Moniteur Belge N [C 2007/22836].

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Alex Kartheuser (Colorectal Surgery, Cliniques universitaires St-Luc, UCL) Authors

More information

B10/S/a Cancer: Malignant Mesothelioma (Adult)

B10/S/a Cancer: Malignant Mesothelioma (Adult) B10/S/a 2013/14 NHS STANDARD CONTRACT FOR CANCER: MALIGNANT MESOTHELIOMA (ADULT) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No. Service Commissioner Lead Provider Lead Period Date

More information

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native

More information

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are

More information

Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines

Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year

More information

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the

More information

Malignant Mesothelioma State of the Art

Malignant Mesothelioma State of the Art Malignant Mesothelioma State of the Art Paul Baas The Netherlands Cancer Institute August 12, 2011, Carlsbad, CA Summary Diagnosis; epithelial type subdivided Pleiomorphic vs other Staging: IASLC-IMIG

More information

There must be an appropriate administrative structure for each residency program.

There must be an appropriate administrative structure for each residency program. Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation

More information

RARE MALIGNANT SKIN TUMOURS PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

RARE MALIGNANT SKIN TUMOURS PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES RARE MALIGNANT SKIN TUMOURS PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Brochez Lieve (Dermatology, UZ Gent) Authors : For melanoma, epithelioma and other rare skin tumours:

More information

Management of Non-Small Cell Lung Cancer Guide for General Practitioners

Management of Non-Small Cell Lung Cancer Guide for General Practitioners Management of n-small Cell Lung Cancer Guide for General Practitioners Clinical Stage I Cancer only in one lobe of lung and

More information

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image

More information

2015/16 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)-

2015/16 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)- 2015/16 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)- SECTION B PART 1 - SERVICE SPECIFICATION FOR LUNG CANCER Service specification

More information

THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY

THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App

More information

Mesothelioma in the UK

Mesothelioma in the UK Mesothelioma in the UK Liz Darlison Mesothelioma UK The National Macmillan Mesothelioma Resource Centre June 2010 Mesothelioma Applied Research Foundation - 2010 www.curemeso.org Contents Size of Mesothelioma

More information

بسم هللا الرحمن الرحيم

بسم هللا الرحمن الرحيم بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma

More information

Lung Cancer & Mesothelioma 2011-2015

Lung Cancer & Mesothelioma 2011-2015 Lung Cancer & Mesothelioma 2011-2015 Annex G Mesothelioma 1. The vision for mesothelioma services is set out in the Mesothelioma Framework issued by DH on 26 February 2007 (supported by the British Thoracic

More information

Malignant Mesothelioma

Malignant Mesothelioma Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)

More information

Malignant Mesothelioma

Malignant Mesothelioma Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)

More information

Cancer Care Delivered Locally by Physicians You Know and Trust

Cancer Care Delivered Locally by Physicians You Know and Trust West Florida Physician Office Building Johnson Ave. University Pkwy. Olive Road N. Davis Hwy. For more information on West Florida Cancer Center: 850-494-5404 2130 East Johnson Avenue Pensacola, Florida

More information

Lung Cancer Consultant Outcomes Publication

Lung Cancer Consultant Outcomes Publication Lung Cancer Consultant Outcomes Publication Introduction This report describes the outcomes of individual consultant thoracic and cardiothoracic surgeons who carry out surgery for lung cancer. It has been

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

Lung Cancer Multidisciplinary Meeting Toolkit. National Lung Cancer Working Group

Lung Cancer Multidisciplinary Meeting Toolkit. National Lung Cancer Working Group Lung Cancer Multidisciplinary Meeting Toolkit National Lung Cancer Working Group September 2014 Contents Introduction 1 Multidisciplinary meetings 1 Toolkit for implementing high-quality lung cancer MDMs

More information

Malignant Mesothelioma: an Update

Malignant Mesothelioma: an Update Malignant Mesothelioma: an Update Nico van Zandwijk Asbestos Diseases Research Institute Bernie Banton Centre University of Sydney Australia Physicians Week RACP 19-5-2009 Health Risks of Asbestos Fibers

More information

The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.

The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Leaders in Prostate Cancer Treatment and Research The Center for Prostate Cancer at the North

More information

Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment

Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment Reference: NHS England xxx/x/x 1 Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy)

More information

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including

More information

Malignant pleural mesothelioma P/D vs. EPP

Malignant pleural mesothelioma P/D vs. EPP 3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy

More information

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,

More information

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Survey of Mesothelioma Associated with Asbestos Exposure in Japan The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics

More information

National Framework for Excellence in

National Framework for Excellence in National Framework for Excellence in Lung Cancer Screening and Continuum of Care declaration of purpose Rights and Expectations THE RIGHTS OF THE PEOPLE Lung cancer kills more Americans than the next four

More information

Treatment Guide Lung Cancer Management

Treatment Guide Lung Cancer Management Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular

More information

Breast. Patient information. cancer clinical pathway

Breast. Patient information. cancer clinical pathway Breast Patient information cancer clinical pathway This leaflet was written to properly inform people following breast cancer treatment plan. It doesn t replace the dialogue with healthcare staff; it rather

More information

International Symposium on Malignant Pleural Mesothelioma

International Symposium on Malignant Pleural Mesothelioma International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear

More information

Management of mesothelioma

Management of mesothelioma Management of mesothelioma Jan.vanmeerbeeck@ugent.be Amsterdam, March 6, 2010 1 management Palliation Symptomatic care Pain Breathlessness Radiotherapy Chemotherapy Surgery Radical (intention to cure)

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

International Journal of Case Reports in Medicine

International Journal of Case Reports in Medicine International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon

More information

Cancer services children s CSCF v3.2

Cancer services children s CSCF v3.2 Cancer services children s CSCF v3.2 Module overview Please note: This module should be read in conjunction with the Fundamentals of the Framework (including glossary and acronym list), Children s Services

More information

ROLE DESCRIPTIONS BY COMPETENCY LEVEL

ROLE DESCRIPTIONS BY COMPETENCY LEVEL Description of Work: Positions in this class provide patient evaluation and care in area of assignment. Duties include but are not limited to development and presentation of educational programs, assessment,

More information

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis

More information

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,

More information

Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW

Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW The treatment you receive will depend on your lung cancer type, for example, whether you have a non-small cell lung cancer Adenocarcinoma or Squamous cell carcinoma, and if this is a sub-type with a mutation.

More information

Training Requirements for the Specialty of Radiation Oncology

Training Requirements for the Specialty of Radiation Oncology Association internationale sans but lucratif AVENUE DE LA COURONNE, 20 BE- 1050 BRUSSELS www.uems.net International non-profit organisation T +32 2 649 51 64 F +32 2 640 37 30 info@uems.net Training Requirements

More information

Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians

Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Background The Cancer Institute New South Wales Oncology Group Lung (NSWOG Lung) identified the need for the development

More information

Pre-workshop exercise

Pre-workshop exercise Setting research priorities for mesothelioma workshop 10 th November 2014 Pre-workshop exercise Your individual ranking of unanswered questions about the diagnosis, treatment and care of mesothelioma Please

More information

Treating Mesothelioma - A Quick Guide

Treating Mesothelioma - A Quick Guide Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information

More information

This vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years

This vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years Breast Cancer 2015 Annex C Background 1. Breast cancer is the most common cancer in women in England with (not including cases of ductal carcinoma in situ (DCIS) 1 ) 39,681 new cases diagnosed in 2008

More information

Cancer research in the Midland Region the prostate and bowel cancer projects

Cancer research in the Midland Region the prostate and bowel cancer projects Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate

More information

PATIENT INFORMATION SHEET

PATIENT INFORMATION SHEET PATIENT INFORMATION SHEET Surgical and large bore pleural procedures in Malignant pleural Mesothelioma And Radiotherapy Trial (SMART trial) Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire

More information

The Center for Cancer Care. Comprehensive and compassionate care

The Center for Cancer Care. Comprehensive and compassionate care The Center for Cancer Care Comprehensive and compassionate care Welcome to the Center for Cancer Care The Center for Cancer Care at Exeter Hospital provides comprehensive, compassionate care for a wide

More information

Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma

Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma I d like to welcome everyone, thanks for coming out to our lunch with experts. The faculty today are great people in the thoracic

More information

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing

More information

Questions to ask your doctor. about Prostate Cancer and selecting a treatment facility

Questions to ask your doctor. about Prostate Cancer and selecting a treatment facility Questions to ask your doctor about Prostate Cancer and selecting a treatment facility The Basics Establishing an open dialogue with a doctor provides you with the opportunity to learn specific information

More information

An Integrated Approach to Lung Cancer in a Community Setting

An Integrated Approach to Lung Cancer in a Community Setting An Integrated Approach to Lung Cancer in a Community Setting The multidisciplinary thoracic clinic at Erie Regional Cancer Center by Jan M. Rothman, MD, and Shelley D. KuBaney, RN, OCN 40 OI May June 2013

More information

SMALL CELL LUNG CANCER

SMALL CELL LUNG CANCER Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New

More information

Lung cancer forms in tissues of the lung, usually in the cells lining air passages.

Lung cancer forms in tissues of the lung, usually in the cells lining air passages. Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)

More information

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.

More information

How do I find the best place to get treatment for my lymphoma?

How do I find the best place to get treatment for my lymphoma? Produced November 2010 Next revision due November 2012 How do I find the best place to get treatment for my lymphoma? Introduction Fortunately this is not a question that patients with cancers of the blood

More information

Understanding Pleural Mesothelioma

Understanding Pleural Mesothelioma Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to

More information

Screening, early referral and treatment for asbestos related cancer

Screening, early referral and treatment for asbestos related cancer Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto Asbestos related diseases Mesothelioma Lung

More information

PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE

PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE MARCH 2013 MONOGRAPHS IN PROSTATE CANCER OUR VISION, MISSION AND VALUES Prostate Cancer Foundation of Australia (PCFA)

More information

Mesothelioma. Malignant Pleural Mesothelioma

Mesothelioma. Malignant Pleural Mesothelioma Mesothelioma William G. Richards, PhD Brigham and Women s Hospital Malignant Pleural Mesothelioma 2,000-3,000 cases per year (USA) Increasing incidence Asbestos (50-80%, decreasing) 30-40 year latency

More information

Advances in Lung Cancer: A Multidisciplinary Approach

Advances in Lung Cancer: A Multidisciplinary Approach Advances in Lung Cancer: A Multidisciplinary Approach Saturday, April 25, 2015 127 Public Square Cleveland, Ohio Learning Objectives About the Course This one-day course will provide a topical, clinically

More information

Palliative Care Role Delineation Framework

Palliative Care Role Delineation Framework Director-General Palliative Care Role Delineation Framework Document Number GL2007_022 Publication date 26-Nov-2007 Functional Sub group Clinical/ Patient Services - Medical Treatment Clinical/ Patient

More information

The East Midlands Mesothelioma Multi-disciplinary Team (MDT) Cancer Services Information for Patients

The East Midlands Mesothelioma Multi-disciplinary Team (MDT) Cancer Services Information for Patients The East Midlands Mesothelioma Multi-disciplinary Team (MDT) Cancer Services Information for Patients i Introduction The team of health professionals looking after you is known as the multidisciplinary

More information

2014 Report of Cancer Program Activities for 2013

2014 Report of Cancer Program Activities for 2013 2014 Report of Cancer Program Activities for 2013 The University of Vermont Health Network-Central Vermont Medical Center (UVMHN-CVMC) Cancer Committee is pleased to present our Cancer Program Annual Report

More information

Asbestos and your lungs

Asbestos and your lungs This information describes what asbestos is and the lung conditions that are caused by exposure to it. It also includes information about what to do if you have been exposed to asbestos, and the benefits

More information

Mesothelioma: Questions and Answers

Mesothelioma: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions

More information

Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer About Your Lungs and Lung Cancer How do your lungs work? To understand lung cancer it is helpful to understand your lungs. Your lungs put oxygen into the blood, which the heart

More information

Malignant Pleural Mesothelioma in Singapore

Malignant Pleural Mesothelioma in Singapore RESEARCH COMMUNICATION C SP Yip 1, HN Koong 2, CM Loo 3, KW Fong 1* Abstract Aim: To examine the clinical characteristics and outcomes of malignant pleural mesothelioma (MPM) in Singapore. Methods and

More information

GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT

GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA 17-18 June 2010 Golnik, Slovenia Chair: T. Cufer, SI - G.L. Ceresoli, IT AIM OF THE COURSE The incidence

More information

Chapter 13. The hospital-based cancer registry

Chapter 13. The hospital-based cancer registry Chapter 13. The hospital-based cancer registry J.L. Young California Tumor Registry, 1812 14th Street, Suite 200, Sacramento, CA 95814, USA Introduction The purposes of a hospital-based cancer registry

More information

Probe: Could you tell me about when?

Probe: Could you tell me about when? PERIODIC ASSESSMENT OF TREATMENT AND VITAL/DISEASE STATUS Periodic Assessment of Cancer Treatment and Disease Status (To be administered to patient at 3 months and reviewed at 6, 9 and 12 months) Instructions:

More information

Lung Cancer in 2015: A Multidisciplinary Update

Lung Cancer in 2015: A Multidisciplinary Update Lung Cancer in 2015: A Multidisciplinary Update Invited Guest Faculty: Toronto General Hospital Toronto, Canada Saturday April 18, 2015 7:00 am-4:30 pm Westin Pasadena 191 N. Los Robles Avenue Pasadena,

More information

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT

More information

The Brain and Spine CenTer

The Brain and Spine CenTer The Br ain and Spine Center Choosing the right treatment partner is important for patients facing tumors involving the brain, spine or skull base. The Brain and Spine Center at The University of Texas

More information

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES Since breast cancer is not a systemic disease from inception, when the imagers find in situ and 1-14 mm invasive breast cancer, it is the surgeon, specialized in the treatment of breast diseases, who should

More information

Breast Health Program

Breast Health Program Breast Health Program Working together, for your health. Breast Health Program The Breast Health Program at The University of Arizona Cancer Center offers patients a personalized approach to breast cancer,

More information

AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life and Pensions Limited

AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life and Pensions Limited AA Life Insurance is provided by Friends Life and Pensions Limited What would be the first thing you might think about if you were diagnosed with a serious illness? 2 It is very likely that the first thing

More information

Surgical therapy of. who should be operated

Surgical therapy of. who should be operated SAMO Interdisciplinary Workshop on Chest Tumors Lucerne, 13th and 14th January 2012 Surgical therapy of mesothelioma, who should be operated Walter Weder MD Professor of Surgery University Hospital Zurich

More information

Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care

Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Saturday, April 27, 2013 Cleveland Marriott Downtown at Key Center 127 Public Square Cleveland, Ohio Learning

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually

More information

Bristol Hospital Cancer Care Center 2015 Annual Report

Bristol Hospital Cancer Care Center 2015 Annual Report Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the

More information

Salisbury Lung Cancer Service (1 of 5)

Salisbury Lung Cancer Service (1 of 5) Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.

More information

Lung Cancer Treatment Guidelines

Lung Cancer Treatment Guidelines Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,

More information

Oxford Lung Cancer and Mesothelioma Multi- Disciplinary Team (MDT)

Oxford Lung Cancer and Mesothelioma Multi- Disciplinary Team (MDT) Oxford University Hospitals NHS Trust Oxford Lung Cancer and Mesothelioma Multi- Disciplinary Team (MDT) This information leaflet explains the role of the Multi-Disciplinary Team and Specialist Nursing

More information

Exploring the Role of Vitamins in Achieving a Healthy Heart

Exploring the Role of Vitamins in Achieving a Healthy Heart Exploring the Role of Vitamins in Achieving a Healthy Heart There are many avenues you can take to keep your heart healthy. The first step you should take is to have a medical professional evaluate the

More information

Medical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA

Medical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA THE UNIVERSITY OF BRITISH COLUMBIA Department of Urologic Sciences Faculty of Medicine Gordon & Leslie Diamond Health Care Centre Level 6, 2775 Laurel Street Vancouver, BC, Canada V5Z 1M9 Tel: (604) 875-4301

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who

More information

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James

More information

Report of Working Groups

Report of Working Groups BD5.3 Report of Working Groups Elimination of Asbestos-related Diseases ICOH 2012 March 18, 2012 Cancun Report of WG Elimination of Asbestos-related Diseases Dr. Sherson mail to ICOH President of 7 December

More information

Please see the LUCADA data manual v3.1.3, available in the downloads section

Please see the LUCADA data manual v3.1.3, available in the downloads section National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands

More information

Specific Standards of Accreditation for Residency Programs in General Surgery

Specific Standards of Accreditation for Residency Programs in General Surgery Specific Standards of Accreditation for Residency Programs in General Surgery 2010 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation of the

More information

Asbestos Related Diseases

Asbestos Related Diseases Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through

More information

Oncology Programme. Oncology Programme 2015 17 August 2015 Page 1 of 15

Oncology Programme. Oncology Programme 2015 17 August 2015 Page 1 of 15 Oncology Programme 2015 Oncology Programme 2015 17 August 2015 Page 1 of 15 Your cover for cancer treatment in 2015 Members who are diagnosed with cancer need to register on the Oncology Programme. Overview

More information

Specific Standards of Accreditation for Residency Programs in Orthopedic Surgery

Specific Standards of Accreditation for Residency Programs in Orthopedic Surgery Specific Standards of Accreditation for Residency Programs in Orthopedic Surgery 2012 INTRODUCTION A university wishing to have an accredited program in Orthopedic Surgery must also sponsor an accredited

More information

Patient Information Leaflet written by the Nurse Specialists, South East Wales Cancer Network - Upper Gastrointestinal Advisory Group.

Patient Information Leaflet written by the Nurse Specialists, South East Wales Cancer Network - Upper Gastrointestinal Advisory Group. These leaflets are reviewed on a regular basis. If you feel we have left out some information that would be useful, please contact your Cancer Nurse Specialist. Patient Information Leaflet written by the

More information

A Practical Guide to Advances in Staging and Treatment of NSCLC

A Practical Guide to Advances in Staging and Treatment of NSCLC A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging

More information